Bray Capital Advisors decreased its stake in shares of CVS Health Corp (NYSE:CVS) by 69.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,754 shares of the pharmacy operator’s stock after selling 19,975 shares during the period. Bray Capital Advisors’ holdings in CVS Health were worth $635,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of CVS. Notis McConarty Edward grew its position in CVS Health by 12.4% in the fourth quarter. Notis McConarty Edward now owns 51,176 shares of the pharmacy operator’s stock valued at $3,711,000 after purchasing an additional 5,650 shares in the last quarter. Meeder Asset Management Inc. grew its position in CVS Health by 261.3% in the fourth quarter. Meeder Asset Management Inc. now owns 68,121 shares of the pharmacy operator’s stock valued at $4,939,000 after purchasing an additional 49,266 shares in the last quarter. Public Employees Retirement Association of Colorado grew its position in CVS Health by 6.9% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 192,948 shares of the pharmacy operator’s stock valued at $13,989,000 after purchasing an additional 12,413 shares in the last quarter. Greenwood Capital Associates LLC bought a new position in CVS Health in the fourth quarter valued at $1,883,000. Finally, Puzo Michael J grew its position in CVS Health by 7.6% in the fourth quarter. Puzo Michael J now owns 73,353 shares of the pharmacy operator’s stock valued at $5,318,000 after purchasing an additional 5,193 shares in the last quarter. 83.96% of the stock is owned by institutional investors.
Shares of CVS stock opened at $62.94 on Wednesday. The company has a market cap of $66,604.02, a price-to-earnings ratio of 9.73, a price-to-earnings-growth ratio of 1.09 and a beta of 1.03. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. CVS Health Corp has a 12 month low of $61.87 and a 12 month high of $84.00.
CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.88 by $0.04. The firm had revenue of $48.39 billion during the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.71 earnings per share. equities research analysts expect that CVS Health Corp will post 6.37 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 3.18%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s dividend payout ratio is currently 30.91%.
CVS has been the subject of a number of analyst reports. Jefferies Group set a $76.00 target price on shares of CVS Health and gave the company a “hold” rating in a research report on Monday, December 4th. Robert W. Baird decreased their target price on shares of CVS Health from $85.00 to $80.00 and set a “neutral” rating for the company in a research report on Friday, February 9th. ValuEngine downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Vetr downgraded shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 target price for the company. in a research report on Thursday, January 4th. Finally, Royal Bank of Canada set a $95.00 target price on shares of CVS Health and gave the company a “buy” rating in a research report on Monday, December 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $87.03.
In other news, EVP Helena Foulkes sold 19,965 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the completion of the sale, the executive vice president now owns 65,072 shares in the company, valued at approximately $4,622,714.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Lisa Bisaccia sold 29,445 shares of the firm’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Bray Capital Advisors Lowers Stake in CVS Health Corp (CVS)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/03/21/bray-capital-advisors-lowers-stake-in-cvs-health-corp-cvs.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.